Compile Data Set for Download or QSAR
Report error Found 10 Enz. Inhib. hit(s) with all data for entry = 12159
Target5-hydroxytryptamine receptor 2A(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM683053(US12023331, Example 1 | US20240307386, Compound Ex...)
Affinity DataKi:  8.30nMAssay Description:Receptor binding is determined for the Compound of Example 1, using the compound of Formula A as a control. The following literature procedures are u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/8/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM683055(US12023331, Example 1A)
Affinity DataKi:  10nMAssay Description:Receptor binding is determined for the Compound of Example 1, using the compound of Formula A as a control. The following literature procedures are u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/8/2024
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM683053(US12023331, Example 1 | US20240307386, Compound Ex...)
Affinity DataKi:  11nMAssay Description:Receptor binding is determined for the Compound of Example 1, using the compound of Formula A as a control. The following literature procedures are u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/8/2024
Entry Details
Go to US Patent

TargetSodium-dependent serotonin transporter(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM683055(US12023331, Example 1A)
Affinity DataKi:  16nMAssay Description:Receptor binding is determined for the Compound of Example 1, using the compound of Formula A as a control. The following literature procedures are u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/8/2024
Entry Details
Go to US Patent

TargetD(1A) dopamine receptor(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM683055(US12023331, Example 1A)
Affinity DataKi:  41nMAssay Description:Receptor binding is determined for the Compound of Example 1, using the compound of Formula A as a control. The following literature procedures are u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/8/2024
Entry Details
Go to US Patent

TargetD(2) dopamine receptor(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM683055(US12023331, Example 1A)
Affinity DataKi:  49nMAssay Description:Receptor binding is determined for the Compound of Example 1, using the compound of Formula A as a control. The following literature procedures are u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/8/2024
Entry Details
Go to US Patent

TargetD(1A) dopamine receptor(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM683053(US12023331, Example 1 | US20240307386, Compound Ex...)
Affinity DataKi:  50nMAssay Description:Receptor binding is determined for the Compound of Example 1, using the compound of Formula A as a control. The following literature procedures are u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/8/2024
Entry Details
Go to US Patent

TargetD(2) dopamine receptor(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM683053(US12023331, Example 1 | US20240307386, Compound Ex...)
Affinity DataKi:  160nMAssay Description:Receptor binding is determined for the Compound of Example 1, using the compound of Formula A as a control. The following literature procedures are u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/8/2024
Entry Details
Go to US Patent

TargetSodium-dependent serotonin transporter(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM683053(US12023331, Example 1 | US20240307386, Compound Ex...)
Affinity DataKi:  590nMAssay Description:Receptor binding is determined for the Compound of Example 1, using the compound of Formula A as a control. The following literature procedures are u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/8/2024
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM683055(US12023331, Example 1A)
Affinity DataKi: >1.00E+4nMAssay Description:Receptor binding is determined for the Compound of Example 1, using the compound of Formula A as a control. The following literature procedures are u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/8/2024
Entry Details
Go to US Patent